PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Ellagic acid protects against arsenic trioxide-induced cardiotoxicity in rat.

Rat / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 28474970 ↗2017Reported benefit

Ellagic acid protects against arsenic trioxide-induced cardiotoxicity in rat.

RatChemical/toxinWistarMalen = 32 rats in four groupsOral30 mg/kgPretreatment 1 hour before each arsenic trioxide injection

Model: Arsenic trioxide-induced cardiotoxicity, arsenic trioxide 5 mg/kg intraperitoneally daily for 10 days

Ellagic acid pretreatment reduced arsenic trioxide-induced changes in glutathione peroxidase and malondialdehyde, shortened QTc prolongation and lowered troponin I and creatine kinase MB, with less cardiac tissue damage.

Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.